SWKS Investors Have Opportunity to Lead Skyworks Solutions, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
SWKS PRNewsWire — March 26, 2025LOS ANGELES , March 26, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skyworks Solutions, Inc. ("Skyworks" or "the Company") (NASDAQ: SWKS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and February 5, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2025.

Amazon Launches 'Interests' AI shopping tool, Reportedly Testing Health Chatbot — Neutral
AMZN Investopedia — March 26, 2025Amazon (AMZN) is testing a new artificial intelligence (AI) shopping tool that finds new products matching a consumer's interests and is also reportedly testing a health-focused chatbot.

Insiders Make Huge Purchases of These 4 Biotech Stocks — Neutral
ATAI IMCR MLYS ZYME 24/7 Wall Street — March 26, 2025After a rough patch, it seems the biotech industry may be staging a comeback. Several biotech firms have gone public this year, and those focused on obesity treatments, gene therapies, and more have high expectations.

Cadence Stock Plunges 10% YTD: How Should You Play the Stock? — Neutral
CDNS Zacks Investment Research — March 26, 2025CDNS' robust portfolio amid increasing design activity is promising, but external risks warrant caution. Investors should wait for a better entry point.

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment — Neutral
SILO GlobeNewsWire — March 26, 2025Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced first dosing in an investigational new drug (IND)-enabling GLP (Good Laboratory Practice)-compliant toxicology and toxicokinetics study of its lead asset, SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD). “This IND-enabling safety study and our concurrent GLP-compliant pharmacokinetic and pharmacodynamic study, if successful, will provide the last preclinical data needed to open an IND for SPC-15,” said Eric …

Sabesp Q4: Privatization Is Making The Company More Agile Every Quarter (Rating Upgrade) — Positive
SBS Seeking Alpha — March 26, 2025I am upgrading my recommendation on Sabesp shares from hold to buy due to strong 4Q24 results, showing revenue and profit growth. Despite a lower EBIT due to redundancy provisions, Sabesp's operational efficiency post-privatization and healthy leverage position support a positive outlook. SBS stock is undervalued, trading at 5.4x EV/EBITDA versus a 5-year average of 6.56x, indicating a potential 21% upside.

Nuclear Energy Stocks to Consider as Demand for Clean Power Grows — Positive
BWXT CEG GEV Zacks Investment Research — March 26, 2025Stocks like BWXT Technologies, GE Vernova and Constellation Energy offer a great opportunity for investors who want to create a nuclear energy portfolio.

GME Crypto Plans, Copper Tariffs Latest & SPX Levels to Watch — Neutral
CPER JJC Schwab Network — March 26, 2025Following reports that Pres. Trump may target import tariffs on Copper (/HG), Kevin Green dives into how that impacts the U.S. economy.

BRP Inc. (DOOO) Beats Q4 Earnings and Revenue Estimates — Positive
DOOO Zacks Investment Research — March 26, 2025BRP Inc. (DOOO) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.81 per share a year ago.

Yoshiharu Announces Financing Agreements Increasing Stockholders' Equity Above the $2.5 Million Threshold Required for Continued Listing on Nasdaq — Neutral
YOSH GlobeNewsWire — March 26, 2025Conversion of Existing $2.5 Million in Debt to Equity and Additional Financing Commitments of $1.65 Million Strengthens Balance Sheet and Lowers Near-Term Cash Needs BUENA PARK, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Yoshiharu Global Co. (NASDAQ: YOSH) ("Yoshiharu" or the "Company"), a restaurant operator specializing in authentic Japanese ramen & rolls, today announced that it entered into additional financing commitments with certain investors for $1.65 million and, as a result of such financing transactions, as of the date hereof, the Company believes that it has regained compliance with the stockholders' equity requirement for continued listing on Nasdaq.

374Water to Participate in Gabelli Funds' 11th Annual Waste, Recycling & Environmental Services Symposium Taking Place April 3rd, 2025 — Neutral
SCWO GlobeNewsWire — March 26, 2025DURHAM, N.C., March 26, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) ("374Water") (the "Company"), a global leader in waste destruction technology for the municipal, federal, and industrial markets, today announced that it will participate in the Gabelli Funds' 11th Annual Waste, Recycling & Environmental Services Symposium taking Place Thursday, April 3rd, 2025, at The Harvard Club, New York City.

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session — Neutral
CDIO Business Wire — March 26, 2025CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.

Graphic Packaging: Steady Volumes Despite A Weak Consumer Environment — Positive
GPK Seeking Alpha — March 26, 2025Graphic Packaging's strategic divestiture of the Augusta facility and investment in the Waco facility aims to optimize capital allocation and enhance long-term profitability. Despite a challenging 2024, the company managed volume pressures and protected margins, with a stable outlook for 2025 driven by innovation and productivity gains. Trading at a discount to peers, Graphic Packaging presents an attractive entry point, with significant upside potential as the Waco facility comes online in late 2025.

The Future of Factors: American Century's Casis Talks Factor ETFs — Neutral
QGRO ETF Trends — March 26, 2025More than three decades have passed since the first ETFs hit the investment landscape. Factor ETFs have long played a key role in helping investors construct portfolios, but are we entering a factor 2.

Buoyed by a spate of mutual-fund-to-ETF conversions, active ETFs made their presence felt in 2024. That accounted for significant percentages of both inflows and launches.

Freeport Declares Quarterly Cash Dividends on Common Stock — Neutral
FCX Business Wire — March 26, 2025PHOENIX--(BUSINESS WIRE)--Freeport (NYSE: FCX) announced today that its Board of Directors declared cash dividends of $0.15 per share on FCX's common stock payable on May 1, 2025, to shareholders of record as of April 15, 2025. The declaration includes a base dividend of $0.075 per share and variable dividend of $0.075 per share in accordance with FCX's performance-based payout framework. The payment of dividends is at the discretion of the Board, which will consider FCX's financial results, ca.

Global Water Announces Pricing of Public Offering of Common Stock — Neutral
GWRS GlobeNewsWire — March 26, 2025PHOENIX, March 26, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, today announced the pricing of an underwritten public offering of 2,800,000 shares of its common stock at a price to the public of $10.00 per share. Certain existing stockholders, including certain directors and/or their affiliates, have agreed to purchase an aggregate of 1,439,200 shares of our common stock in the offering.

Amex GBT Receives Credit Rating Upgrade; Moody's Upgrades the Company to B1 — Neutral
AXP Business Wire — March 26, 2025NEW YORK--(BUSINESS WIRE)--Amex GBT Receives Credit Rating Upgrade; Moody's Upgrades the Company to B1.

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry — Neutral
INBS GlobeNewsWire — March 26, 2025Company's 6 th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology

ROCHESTER, N.Y.--(BUSINESS WIRE)--Paychex, Inc. (the "Company," "Paychex," "we," "our," or "us") today reported results for the fiscal quarter ended February 28, 2025 (the "third quarter"). Results compared with the same period last year were as follows: For the three months ended For the nine months ended In millions, except per share amounts February 28, 2025 February 29, 2024 Change(2) February 28, 2025 February 29, 2024 Change(2) Total revenue $ 1,509.0 $ 1,439.3 5 % $ 4,144.4 $ 3,983.
